Mathematical model for chemotherapeutic drug efficacy in arresting tumour growth based on the cancer stem cell hypothesis

被引:35
作者
Ganguly, R.
Puri, I. K.
机构
[1] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA
[2] Univ Jadavpur, Dept Power Engn, Kolkata 700032, W Bengal, India
关键词
D O I
10.1111/j.1365-2184.2007.00434.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: Cancer stem cells have been identified as the growth root for various malignant tumours and are thought to be responsible for cancer recurrence following treatment. Materials and methods: Here, a predictive mathematical model for the cancer stem cell hypothesis is used to understand tumour responses to chemotherapeutic drugs and judge the efficacy of treatments in arresting tumour growth. The impact of varying drug efficacies on different abnormal cell populations is investigated through the kinetics associated with their decline in response to therapy. Results and conclusions: The model predicts the clinically established 'dandelion phenomenon' and suggests that the best response to chemotherapy occurs when a drug targets abnormal stem cells. We compare continuous and periodic drug infusion. For the latter, we examine the relative importance of the drug cell-kill rate and the mean time between successive therapies, to identify the key attributes for successful treatment.
引用
收藏
页码:338 / 354
页数:17
相关论文
共 35 条
[1]   Therapeutic implications of cancer stem cells [J].
Al-Hajj, M ;
Becker, MW ;
Wichal, M ;
Weissman, I ;
Clarke, MF .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2004, 14 (01) :43-47
[2]   Self-renewal and solid tumor stem cells [J].
Al-Hajj, M ;
Clarke, MF .
ONCOGENE, 2004, 23 (43) :7274-7282
[3]   Chronic myeloid leukemia and interferon-α:: a study of complete cytogenetic responders [J].
Bonifazi, F ;
de Vivo, A ;
Rosti, G ;
Guilhot, F ;
Guilhot, J ;
Trabacchi, E ;
Hehlmann, R ;
Hochhaus, A ;
Shepherd, PCA ;
Steegmann, JL ;
Kluin-Nelemans, HC ;
Thaler, J ;
Simonsson, B ;
Louwagie, A ;
Reiffers, J ;
Mahon, FX ;
Montefusco, E ;
Alimena, G ;
Hasford, J ;
Richards, S ;
Saglio, G ;
Testoni, N ;
Martinelli, G ;
Tura, S ;
Baccarani, M .
BLOOD, 2001, 98 (10) :3074-3081
[4]   Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? [J].
Brenton, JD ;
Carey, LA ;
Ahmed, AA ;
Caldas, C .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) :7350-7360
[5]  
Byrne HM, 2003, MATH COMP BIOL SER, P75
[6]   Neurobiology: At the root of brain cancer [J].
Clarke, MF .
NATURE, 2004, 432 (7015) :281-282
[7]   To the editor: Discontinuation of imatinib therapy after achieving a molecular response [J].
Cortes, J ;
O'Brien, S ;
Kantarjian, H .
BLOOD, 2004, 104 (07) :2204-2205
[8]   Mathematical model for the cancer stem cell hypothesis [J].
Ganguly, R ;
Puri, IK .
CELL PROLIFERATION, 2006, 39 (01) :3-14
[9]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[10]   Strategies to eliminate cancer stem cells: Clinical implications [J].
Huff, CA ;
Matsui, WH ;
Smith, BD ;
Jones, RJ .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (09) :1293-1297